Your browser doesn't support javascript.
loading
Are interleukin 17 and interleukin 23 inhibitors associated with malignancies?-Insights from an international population-based study.
Kridin, Khalaf; Abdelghaffar, Mariam; Mruwat, Noor; Ludwig, Ralf J; Thaçi, Diamant.
Affiliation
  • Kridin K; Lubeck Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
  • Abdelghaffar M; Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
  • Mruwat N; Unit of Dermatology and Skin Research Laboratory, Galilee Medical Center, Nahariya, Israel.
  • Ludwig RJ; School of Medicine, Royal College of Surgeons in Ireland, Busaiteen, Bahrain.
  • Thaçi D; Unit of Dermatology and Skin Research Laboratory, Galilee Medical Center, Nahariya, Israel.
J Eur Acad Dermatol Venereol ; 38(2): 315-324, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37730962

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Antirheumatic Agents / Melanoma Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Antirheumatic Agents / Melanoma Type of study: Observational_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2024 Document type: Article Affiliation country: